Ventricular fibrillation secondary to ergotamine in a healthy young woman

Acta Cardiologica

Volumn 54, Issue 5, 1999, Pages 283-286

  Velez Roa, Sonia ^a   Preumont, Nicolas ^a   Mols, Pierre ^b   Stoupel, Eric ^a   Renard, Marc ^a  

^a ERASME HOSPITAL   (Belgium)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Ergotamine; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

ANTIMIGRAINE AGENT; ERGOTAMINE TARTRATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY SPASM; DEFIBRILLATION; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; MIGRAINE;

ADULT; ANALGESICS, NON-NARCOTIC; CORONARY ANGIOGRAPHY; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; ERGOTAMINE; FEMALE; HUMANS; MIGRAINE DISORDERS; VENTRICULAR FIBRILLATION;

EID: 0032722497     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Benedict CR, Robertson D. Angina pectoris and sudden death in the absence of atherosclerosis following ergotamine therapy for migraine. Am J Med 1979; 67: 177-178.
2. Yasue H, Omote S, Nagao M. Acute myocardial infarction induced by ergotamine tartrate: possible role of coronary arterial spasm. Angiology 1981; 32: 414-418.
3. Baudouy PY, Mellat, M, Valleteau de Moulliac M. Myocardial infarct caused by an ergotamine tartrate-troleandomycin combination. Rev Med Interne 1988; 9: 420-422.
4. Roithinger FX, Punzengruber C, Gremmel F, Hinterreiter M, Holzner F, Pachinger O. Myocardial infarction after chronic ergotamine abuse. Eur Heart J 1993; 14: 1579-1581.
5. Koh KK, Roe IH, Lee MM, Cho SK, Kim SS. Variant angina complicating ergot therapy of migraine. Chest 1994; 105: 1259-1260.
6. Galer BS, Lipton RB, Solomon S, Newman LC, Spierings ELH. Myocardial ischaemia related to ergot alkaloids: a case report and literature review. Headache 1991; 31: 446-450.
7. Bax WA, Renzenbrink GJ, Van Heuven-Nolsen D, Thijssen EJM, Bos E, Saxena PR. 5-HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacology 1993; 239: 203-210.
8. Maassen Van Den Brink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 1998; 98: 25-30.
9. Winbury MM, Howe BB. Stenosis: regional myocardial reserve and reserve. In: Winbury MM, Abiko Y, eds. Ischaemic myocardium and antianginal drugs. Raven Press, New York, 1979: 55-76.
10. Priori SG, Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and the Idiopathic Ventricular Fibrillation Registry of the United states. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Circulation 1997; 95: 265-272.